Jim Cramer highlighted Pfizer as a defensive, dividend-rich stock amid economic uncertainty, while the company and Valneva reported strong phase three results for their Lyme disease vaccine. The shot ...

Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. 1. Stocks rose on Thursday as traders looked to ...

Pfizer Inc. (NYSE:PFE) was among the stocks on Jim Cramer’s radar on Mad Money as he discussed the upcoming earnings. Cramer noted that the stock was cheap with a good yield, as he remarked: Hey, can ...

Jim Cramer reviewed Pfizer Inc. (NYSE:PFE) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. Cramer mentioned the stock during the episode and said: In a ...